Do specialist pulmonologists appropriately utilise thoracic surgery for drug-resistant pulmonary tuberculosis? A survey
- PMID: 34541507
- PMCID: PMC8424776
- DOI: 10.7196/SARJ.2018.v24i3.185
Do specialist pulmonologists appropriately utilise thoracic surgery for drug-resistant pulmonary tuberculosis? A survey
Abstract
Background: Adjuvant lung resection in patients with drug-resistant tuberculosis (DR-TB) not only is cheaper than a 2-month course of drug therapy for multidrug-resistant tuberculosis (MDR-TB) but also, more importantly, has a higher cure rate than medical therapy alone. The cure rate for some MDR-TB patients treated with adjuvant lung resection is about 90%. With the more severe forms of DR-TB, surgical cure rates in selected patients remain high, whereas cure rates decrease when only medical therapy is used. In addition, adjuvant lung resection for DR-TB in selected patients with HIV co-infection does not appear to have a higher complication rate.
Objectives: To determine whether specialist pulmonologists in South Africa utilise thoracic surgical intervention for DR-TB appropriately.
Methods: A cross-sectional survey was conducted among pulmonologists of the South African Thoracic Society. The study tool was a predesigned, anonymous questionnaire that included 17 closed-ended questions about the role of cardiothoracic surgery in the management of DR-TB.
Results: A 50% response rate was achieved. The majority of respondents did not know the indications for adjuvant lung surgery in the setting of DR-TB, but would have altered their referral behaviour had they been aware of these indications.
Conclusion: Participating pulmonologists' uncertainty regarding optimal use of adjuvant lung resection for DR-TB suggests the need for local guidelines and education initiatives relevant to the management of these patients. These strategies should include the participation of both the pulmonologist and the cardiothoracic surgeon.
Keywords: adjuvant lung resection; drug-resistant tuberculosis; multidisciplinary teams; thoracic surgery.
Conflict of interest statement
Conflicts of interest: None.
References
-
- World Health Organization (WHO) Geneva: WHO; 2015. Global Tuberculosis Report 2015.
-
- Statistics South Africa (Stats SA) Pretoria: Stats SA; 2017. Mortality and causes of death in South Africa, 2015: Findings from death notification.
-
- TB Alliance. The Cycle of Poverty. https://www.tballiance.org/whynew-tb-drugs/cycle-poverty (accessed 30 August 2018)
LinkOut - more resources
Full Text Sources